Mirum Pharmaceuticals Inc's Comment on Supply Chain
The company utilizes multiple third-party contract manufacturers for raw materials, active pharmaceutical ingredients, and finished products, including clinical supplies. It has an agreement with Lonza for the manufacture of brelovitug. There are currently no contractual arrangements for the manufacture of commercial supplies of volixibat. Manufacturing contractors are managed by internal resources and third-party consultants.
Mirum Pharmaceuticals Inc's Comment on Supply Chain
The company utilizes multiple third-party contract manufacturers for raw materials, active pharmaceutical ingredients, and finished products, including clinical supplies. It has an agreement with Lonza for the manufacture of brelovitug. There are currently no contractual arrangements for the manufacture of commercial supplies of volixibat. Manufacturing contractors are managed by internal resources and third-party consultants.
Sources:
Mirum Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Mirum Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
